Report and Indices
GLASS Report 2022
Global antimicrobial resistance and use surveillance system (GLASS) report, 2022 was released by the World Health Organisation (WHO)
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015. It is the first global collaborative effort to standardize AMR surveillance.
In 2015 WHO launched the Global Action Plan to tackle AMR (GAP-AMR). The goal of GAP-AMR is to foster Antimicrobial Resistance (AMR) surveillance and inform strategies to contain AMR.
The report summarises global AMR and Antimicrobial Consumption (AMC) data to date.
The report shows high levels (above 50%) of resistance were reported in bacteria frequently.
Note
AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat.
Government of India has taken following initiatives to increase awareness about antibiotics misuse:
ICMR (Indian Council of Medical Research) has initiated antibiotic stewardship program (AMSP) on a pilot project basis in 20 tertiary care hospitals across India to control misuse and overuse of antibiotics in hospital wards and ICUs.
ICMR worked in collaboration with Indian Council of Agriculture Research, Department of Animal Husbandry, Dairy and Fisheries and the DCGI to ban use of Colistin as growth promoter in animal feed in poultry.
National action plan on containment of Antimicrobial Resistance (NAP-AMR) focusing on One Health approach was launched in April 2017.
AMR Surveillance Network: ICMR AMR surveillance and research network (AMRSN) comprising 30 tertiary care hospitals, both private and government, to generate evidence and capture trends and patterns of drug resistant infections in the country.
AMR Research & International Collaboration: ICMR develops new drugs /medicines through international collaborations in order to strengthen medical research in AMR.
